- Home
- TCBI vs LIVN Comparison
TCBI vs LIVN Comparison
Compare TCBI & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBI | LIVN |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.5B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | TCBI | LIVN |
|---|---|---|
| Price | $99.52 | $59.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $100.92 | $72.43 |
| AVG Volume (30 Days) | 380.6K | ★ 646.5K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.76 | $9.79 |
| Revenue Next Year | $7.47 | $6.63 |
| P/E Ratio | $15.46 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.74 | $35.00 |
| 52 Week High | $108.92 | $71.58 |
Technical Indicators
Market Signals| Indicator | TCBI | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 37.15 |
| Support Level | $81.58 | $58.14 |
| Resistance Level | $106.94 | $65.61 |
| Average True Range (ATR) | 2.95 | 2.06 |
| MACD | -0.48 | -0.61 |
| Stochastic Oscillator | 31.79 | 9.23 |
Price Performance
Historical ComparisonAbout TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.